BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9584605)

  • 41. Women's preventive screening in rural health clinics.
    Edwards JB; Tudiver F
    Womens Health Issues; 2008; 18(3):155-66. PubMed ID: 18457753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy.
    Crocetti E; Battisti L; Betta A; Palma PD; Paci E; Piffer S; Pojer A; Polla E; Zappa M
    Eur J Cancer Prev; 2007 Dec; 16(6):564-7. PubMed ID: 18090131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficiency of preventive care examinations in carcinoma of the uterine cervix].
    Zinser HK
    Fortschr Med; 1974 Mar; 92(9):357-9. PubMed ID: 4819503
    [No Abstract]   [Full Text] [Related]  

  • 44. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Screening and diagnosis of cervical cancer].
    Boulanger JC; Naepels P
    Rev Prat; 2001 Sep; 51(13):1426-31. PubMed ID: 11601071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inadequacy of cervical cancer screening among urban recent immigrants: a population-based study of physician and laboratory claims in Toronto, Canada.
    Lofters A; Glazier RH; Agha MM; Creatore MI; Moineddin R
    Prev Med; 2007 Jun; 44(6):536-42. PubMed ID: 17467782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Responses, actions and health-promoting behavior among rural Taiwanese women with abnormal Papanicolaou test.
    Liou HI; Ling XM; Feng MX; Guo YL; Chen MY
    Public Health Nurs; 2009; 26(2):134-43. PubMed ID: 19261152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996].
    Bos AB; van Ballegooijen M; van den Akker-van Marle ME; Habbema JD
    Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1586-90. PubMed ID: 12224483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cervical cancer screening in Thailand: an overview.
    Sriamporn S; Khuhaprema T; Parkin M
    J Med Screen; 2006; 13 Suppl 1():S39-43. PubMed ID: 17227641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cervical cancers diagnosed at the Pasteur Institute of Madagascar from 1992 to 2002].
    Raharisolo Vololonantenaina CR; Rabarijaona LP; Soares JL; Rasendramino M; Pécarrère JL; Khun H; Huerre M
    Arch Inst Pasteur Madagascar; 2003; 69(1-2):77-81. PubMed ID: 15678821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Screening for precancerous conditions and preclinical carcinoma of the uterine cervix in the Western Bohemian Region].
    Bouda J; Mleziva J; Filaun J; Plánicková E
    Cesk Gynekol; 1990 Sep; 55(8):629-34. PubMed ID: 2225130
    [No Abstract]   [Full Text] [Related]  

  • 54. [Systematic screening for cervix uteri cancer in the hospital].
    Chabert P
    Rev Fr Gynecol Obstet; 1971; 66(11):647-9. PubMed ID: 5148538
    [No Abstract]   [Full Text] [Related]  

  • 55. [Incidence of cervical cancer 5 years after mass screening in the community of Medvesćak].
    Juras N; Tućan V; Pirkić A; Sućur A
    Acta Med Iugosl; 1984; 38(3):197-202. PubMed ID: 6496168
    [No Abstract]   [Full Text] [Related]  

  • 56. [Vaginal cytologic studies on a venerologic clientele].
    Hjortishoj A; Hastrup J; Schultz H
    Ugeskr Laeger; 1974 Jul; 136(29):1639-41. PubMed ID: 4407969
    [No Abstract]   [Full Text] [Related]  

  • 57. [Mammographic screening and the Pap test combined: the experience of Empoli].
    Salvadori P
    Epidemiol Prev; 1996; 20(2-3):150-1. PubMed ID: 8766307
    [No Abstract]   [Full Text] [Related]  

  • 58. Global gleanings.
    Isbell NP
    Acta Cytol; 1970 May; 14(5):237-8. PubMed ID: 5284261
    [No Abstract]   [Full Text] [Related]  

  • 59. Rescreening of Pap smears.
    Maughan KL
    J Fam Pract; 1998 Apr; 46(4):279-80. PubMed ID: 9564365
    [No Abstract]   [Full Text] [Related]  

  • 60. [Dysplasia and carcinoma in situ of the cervix inmass screening].
    Nishiya I
    Gan No Rinsho; 1970; 16(3):214-5. PubMed ID: 5463016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.